Search

Scarlett Y. Goon

Supervisory Patent Examiner (ID: 11557, Phone: (571)270-5241 , Office: P/1600 )

Most Active Art Unit
1623
Art Unit(s)
1673, 1693, 1600, 1623, 4131
Total Applications
525
Issued Applications
185
Pending Applications
17
Abandoned Applications
329

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6080392 [patent_doc_number] => 20110142971 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'USE OF AN ONION EXTRACT FOR MAKING A COMPOSITION TO CONTROL WEIGHT GAIN' [patent_app_type] => utility [patent_app_number] => 13/034847 [patent_app_country] => US [patent_app_date] => 2011-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7568 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20110142971.pdf [firstpage_image] =>[orig_patent_app_number] => 13034847 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/034847
USE OF AN ONION EXTRACT FOR MAKING A COMPOSITION TO CONTROL WEIGHT GAIN Feb 24, 2011 Abandoned
Array ( [id] => 6084825 [patent_doc_number] => 20110144316 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'METHOD FOR RESTRUCTURING THE EPIDERMIS USING A POLYOL-GLYCOSIDE COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/031681 [patent_app_country] => US [patent_app_date] => 2011-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6357 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144316.pdf [firstpage_image] =>[orig_patent_app_number] => 13031681 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/031681
Method for restructuring the epidermis using a polyol-glycoside composition Feb 21, 2011 Issued
Array ( [id] => 7560946 [patent_doc_number] => 20110274778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases' [patent_app_type] => utility [patent_app_number] => 12/929684 [patent_app_country] => US [patent_app_date] => 2011-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11047 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20110274778.pdf [firstpage_image] =>[orig_patent_app_number] => 12929684 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/929684
Use of a compound comprising D-mannoheptulose and/or perseitol for treating and preventing innate immunity modification diseases Feb 7, 2011 Issued
Array ( [id] => 6186336 [patent_doc_number] => 20110124596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'COMPOSITION FOR TREATING INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 13/019761 [patent_app_country] => US [patent_app_date] => 2011-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2810 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124596.pdf [firstpage_image] =>[orig_patent_app_number] => 13019761 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/019761
COMPOSITION FOR TREATING INFLAMMATORY DISEASES Feb 1, 2011 Abandoned
Array ( [id] => 6187028 [patent_doc_number] => 20110124850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'Glycorandomization and Production of Novel Vancomycin Analogs' [patent_app_type] => utility [patent_app_number] => 13/018811 [patent_app_country] => US [patent_app_date] => 2011-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 36192 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124850.pdf [firstpage_image] =>[orig_patent_app_number] => 13018811 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/018811
Glycorandomization and production of novel erythromycin analogs Jan 31, 2011 Issued
Array ( [id] => 9937410 [patent_doc_number] => 08987216 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-24 [patent_title] => 'Polysulfated glycosides and salts thereof' [patent_app_type] => utility [patent_app_number] => 13/013153 [patent_app_country] => US [patent_app_date] => 2011-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16718 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13013153 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/013153
Polysulfated glycosides and salts thereof Jan 24, 2011 Issued
Array ( [id] => 8649577 [patent_doc_number] => 20130035307 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-07 [patent_title] => 'METHODS FOR TREATING OR PREVENTING THE SPREAD OF CANCER USING SEMI-SYNTHETIC GLYCOSAMINOGLYCOSAN ETHERS' [patent_app_type] => utility [patent_app_number] => 13/575069 [patent_app_country] => US [patent_app_date] => 2011-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 15261 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575069 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/575069
METHODS FOR TREATING OR PREVENTING THE SPREAD OF CANCER USING SEMI-SYNTHETIC GLYCOSAMINOGLYCOSAN ETHERS Jan 23, 2011 Abandoned
Array ( [id] => 8768038 [patent_doc_number] => 20130096075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-18 [patent_title] => 'COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF METABOLIC SYNDROME' [patent_app_type] => utility [patent_app_number] => 13/261527 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6025 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13261527 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/261527
COMPOSITION FOR PREVENTION, AMELIORATION OR TREATMENT OF METABOLIC SYNDROME Jan 13, 2011 Abandoned
Array ( [id] => 10089145 [patent_doc_number] => 09125953 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-08 [patent_title] => 'Halogenated ether complex' [patent_app_type] => utility [patent_app_number] => 13/522109 [patent_app_country] => US [patent_app_date] => 2011-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1993 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13522109 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/522109
Halogenated ether complex Jan 13, 2011 Issued
Array ( [id] => 6038354 [patent_doc_number] => 20110091403 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE' [patent_app_type] => utility [patent_app_number] => 12/977317 [patent_app_country] => US [patent_app_date] => 2010-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12976 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20110091403.pdf [firstpage_image] =>[orig_patent_app_number] => 12977317 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/977317
OLIGOSACCHARIDE ALDONIC ACIDS AND THEIR TOPICAL USE Dec 22, 2010 Abandoned
Array ( [id] => 6120022 [patent_doc_number] => 20110083991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'HYALURONIC ACID DERIVATIVE AND DRUG CONTAINING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/971361 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29471 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20110083991.pdf [firstpage_image] =>[orig_patent_app_number] => 12971361 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/971361
HYALURONIC ACID DERIVATIVE AND DRUG CONTAINING THE SAME Dec 16, 2010 Abandoned
Array ( [id] => 6064902 [patent_doc_number] => 20110201794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-18 [patent_title] => 'Disaccharides for drug discovery' [patent_app_type] => utility [patent_app_number] => 12/926913 [patent_app_country] => US [patent_app_date] => 2010-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16101 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0201/20110201794.pdf [firstpage_image] =>[orig_patent_app_number] => 12926913 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/926913
Disaccharides for drug discovery Dec 16, 2010 Abandoned
Array ( [id] => 6122016 [patent_doc_number] => 20110077391 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-31 [patent_title] => 'HYDROXYALKYL METHYLCELLULOSE HAVING SOLUBILITY AND THERMOREVERSIBLE GELATION PROPERTIES IMPROVED' [patent_app_type] => utility [patent_app_number] => 12/961006 [patent_app_country] => US [patent_app_date] => 2010-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5074 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20110077391.pdf [firstpage_image] =>[orig_patent_app_number] => 12961006 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/961006
Hydroxyalkyl methylcellulose having solubility and thermoreversible gelation properties improved Dec 5, 2010 Issued
Array ( [id] => 6084846 [patent_doc_number] => 20110144322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-16 [patent_title] => 'Hydroxypropylmethylcellulose Having High Thermal Gel Strength, Method For Producing The Same And Food Comprising The Hydroxypropylmethylcellulose' [patent_app_type] => utility [patent_app_number] => 12/959659 [patent_app_country] => US [patent_app_date] => 2010-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7371 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0144/20110144322.pdf [firstpage_image] =>[orig_patent_app_number] => 12959659 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/959659
Hydroxypropylmethylcellulose Having High Thermal Gel Strength, Method For Producing The Same And Food Comprising The Hydroxypropylmethylcellulose Dec 2, 2010 Abandoned
Array ( [id] => 8496454 [patent_doc_number] => 20120295863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases' [patent_app_type] => utility [patent_app_number] => 13/508797 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16692 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508797 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/508797
Dual-Action Compounds Targeting Adenosine A2A Receptor and Adenosine Transporter for Prevention and Treatment of Neurodegenerative Diseases Nov 11, 2010 Abandoned
Array ( [id] => 10057288 [patent_doc_number] => 09096633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-04 [patent_title] => 'Stable needle-shaped crystals of natamycin' [patent_app_type] => utility [patent_app_number] => 12/926283 [patent_app_country] => US [patent_app_date] => 2010-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3702 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12926283 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/926283
Stable needle-shaped crystals of natamycin Nov 7, 2010 Issued
Array ( [id] => 6184301 [patent_doc_number] => 20110123692 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'CRYSTALLIZATION OF POLYOL COMPOSITIONS, CRYSTALLINE POLYOL COMPOSITION PRODUCT AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/914317 [patent_app_country] => US [patent_app_date] => 2010-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9844 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20110123692.pdf [firstpage_image] =>[orig_patent_app_number] => 12914317 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/914317
Crystallization of polyol compositions, crystalline polyol composition product and use thereof Oct 27, 2010 Issued
Array ( [id] => 8347904 [patent_doc_number] => 20120208827 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-16 [patent_title] => 'BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS' [patent_app_type] => utility [patent_app_number] => 13/504547 [patent_app_country] => US [patent_app_date] => 2010-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47441 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504547 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/504547
BENZIMIDAZOLES AS FATTY ACID SYNTHASE INHIBITORS Oct 26, 2010 Abandoned
Array ( [id] => 6195635 [patent_doc_number] => 20110027390 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Methods for Reducing Cisplatin Nephrotoxicity' [patent_app_type] => utility [patent_app_number] => 12/903934 [patent_app_country] => US [patent_app_date] => 2010-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11276 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20110027390.pdf [firstpage_image] =>[orig_patent_app_number] => 12903934 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/903934
Methods for Reducing Cisplatin Nephrotoxicity Oct 12, 2010 Abandoned
Array ( [id] => 6196655 [patent_doc_number] => 20110028413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'Methods of Reducing Methotrexate Nephrotoxicity' [patent_app_type] => utility [patent_app_number] => 12/903950 [patent_app_country] => US [patent_app_date] => 2010-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 11277 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028413.pdf [firstpage_image] =>[orig_patent_app_number] => 12903950 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/903950
Methods of Reducing Methotrexate Nephrotoxicity Oct 12, 2010 Abandoned
Menu